Figure 3

Comparison of demographic and clinical characteristics between monitored and non-monitored long-term users. Statistically significant differences (P < 0.001) were observed across all compared items. HCQ hydroxychloroquine, SLE systemic lupus erythematosus, RA rheumatoid arthritis.